Europe's food safety authority has put a name to a problem operators already feel: regulatory uncertainty is blocking food innovation across the continent. The warning comes from the European Food Safety Authority (EFSA), the body whose scientific opinions gate what new ingredients, processes and products can reach European plates.

For hotel groups, restaurant chains and food manufacturers, the message matters because it touches the pipeline. Novel foods, alternative proteins and reformulated products all pass through the EFSA assessment route before they can be sold in the EU. If that route is unclear, the industry's development calendars slip.

What did the agency actually say?

EFSA's position, as reported by Food Manufacture, is blunt: the current regulatory framework creates uncertainty, and that uncertainty discourages innovation. The agency isn't arguing for weaker safety checks. It's arguing that unclear or unpredictable rules make it harder for companies to invest in new products, because firms can't judge what evidence regulators will demand or how long approval will take.

That distinction matters. The problem isn't the safety standard itself. It's the fog around how the standard gets applied.

Why does this matter for hospitality operators?

Food service businesses sit at the end of the novel-food pipeline. When ingredient approvals slow down, menu innovation slows with it. Chains planning reformulation around alternative proteins, precision-fermentation ingredients or new additives have to wait on the same assessments EFSA flags as uncertain.

Suppliers feel it first, then pass the delay downstream. A manufacturer that can't predict an approval timeline won't commit production capacity, and a restaurant group won't build a menu launch around an ingredient that may not clear.

The takeaway: unclear rules at the assessment stage translate directly into slower menu and product cycles for European hospitality.

What happens next?

EFSA's public framing suggests pressure is building for the European Commission to clarify how novel-food assessments work. Food industry bodies have long pushed for faster, more predictable approvals, and an agency admitting the system creates uncertainty strengthens that case.

Watch for Commission follow-up: possible guidance revisions, streamlined assessment procedures, or legislative proposals on novel foods. Until Brussels acts, operators should expect the current pace of ingredient approvals — and the innovation delays that come with it — to hold.